Use of GnRHa During Chemotherapy for Fertility Protection
Conditions
Breast Cancer Female · Acute Leukemia · Lymphoma · Osteosarcoma · Soft Tissue Sarcoma · Ewing Sarcoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Center for Pediatric Cancer, Queen Silvia Hospital for Children and Youth, Gothenburg, Sweden
Contact: Study coordinator (Karin Mellgren)Center for Pediatric Oncology, Akademiska Hospital, Gothenburg, Sweden
Contact: Study coordinator (Per Frisk)Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden
Contact: Study coordinator (Barbro Linderholm)Department of Hematology, Skåne University Hospital, Lund, Sweden
Contact: Study coordinator (Niklas Loman)Department of Oncology, Skåne University Hospital, Lund, Sweden
Contact: Study coordinator (Mats Jerkerman)Department of Pediatric Oncology, Skåne University Hospital, Lund, Sweden
Contact: Study coordinator (Helena Mörse)Department of Oncology, Örebro University Hospital, Örebro, Sweden
Karolinska Univeristy Hospital, Breast Centre, Stockholm, Sweden
Department of Hematology and coagulation, Sahlgrenska University Hospital, Stockholm, Sweden
Contact: Study coordinator (Lovisa Vennström)Department of Hematology, Capio ST. Göran Hospital, Stockholm, Sweden
Contact: Study coordinator (Barbro Kedinge)Department of Internal Medicine, Södersjukhuset, Stockholm, Sweden
Contact: Study coordinator (Annelie Liljegren)Department of Oncology, Capio ST. Göran Hospital, Stockholm, Sweden
Contact: Study coordinator (Erika Isaksson Friman)Department of Oncology, Södersjukhuset, Stockholm, Sweden
Contact: Study coordinator (Christina Linder-Stragliotto)Division of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden
Contact: Study coordinator (Per Ljungman)Karolinska University Hospital, Hematology, Stockholm, Sweden
Karolinska University Hospital, High Specialised Pediatric Medicine, Stockholm, Sweden
Department of Oncology, Norrlands University Hospital, Umeå, Sweden
Contact: Study coordinator (Anne Andersson)